Home›Stock Screener›Bayer Crop Science›Financial Statements

Bayer Crop Science Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2025, Bayer Crop Science (BAYERCROP) reported revenue ₹5,593 Cr, net profit ₹568 Cr and EPS ₹126.38, with a net profit margin of 10.2% and ROE of 19.2%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review BAYERCROP PE ratio trends to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 10.16% 2025 data
EBITDA Margin 14.46% 2025 data
Operating Margin 13.00% 2025 data
Return on Assets 9.97% 2025 data
Return on Equity 19.15% 2025 data

Balance Sheet Ratios

Current Ratio 29.63 2025 data
Equity Ratio 52.04% 2025 data
Asset Turnover 0.98 2025 data

BAYERCROP Revenue, Net Profit & EBITDA — Year-on-Year Growth

BAYERCROP YoY (March 2024 vs March 2025) — revenue +7.9%, net profit -23.3%, EBITDA -21.8%, expenses +15.3%. Explore Bayer Crop Science intrinsic worth to estimate fundamental worth using multiple valuation models.

Revenue Growth
+7.9%
Year-over-Year
Net Profit Growth
-23.3%
Year-over-Year
EBITDA Growth
-21.8%
Year-over-Year
Expense Growth
+15.3%
Year-over-Year
Assets Growth
+8.6%
Year-over-Year
Equity Growth
+4.1%
Year-over-Year
Operating Cash Flow Growth
-72.5%
Year-over-Year
Financing Cash Flow Growth
+5.6%
Year-over-Year

BAYERCROP Income Statement — Revenue, EBITDA & Net Profit

Bayer Crop Science revenue ₹5,593 Cr, EBITDA ₹809 Cr, net profit ₹568 Cr, EPS ₹126.38 (2025) — net profit margin 10.2%. For live price, earnings ratios and company overview, see BAYERCROP stock price BSE.

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 5,593 5,184 5,204 4,789 4,325 3,675 3,220 2,749 2,873 2,851 3,811
Expenses 4,784 4,149 4,216 3,923 3,450 2,883 2,686 2,301 2,389 2,334 3,208
EBITDA 809 1,035 988 866 876 792 534 448 484 516 603
Operating Profit Margin % 13.00% 19.00% 18.00% 17.00% 19.00% 20.00% 15.00% 15.00% 15.00% 16.00% 14.00%
Depreciation 85 74 80 65 74 65 44 33 29 25 25
Interest 17 20 22 13 13 14 10 11 7 10 5
Profit Before Tax 707 941 990 847 795 583 480 404 448 482 574
Tax 139 201 232 202 301 109 143 104 157 167 191
Net Profit 568 741 758 645 493 475 337 300 291 315 383
Earnings Per Share (₹) 126.38 164.77 168.71 143.58 109.72 105.58 78.46 86.16 82.31 87.34 104.59

BAYERCROP Balance Sheet — Assets, Liabilities & Shareholders' Equity

BAYERCROP total assets ₹5,699 Cr, total equity ₹2,966 Cr, total liabilities ₹ Cr (2026) — ROE 19.2%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 5,699 5,246 4,597 4,679 4,353 4,239 3,836 3,549 2,535 2,825 2,437 2,773
Current Assets 4,918 4,472 3,906 3,896 3,576 3,544 3,014 2,780 2,076 2,374 2,022 2,370
Fixed Assets 586 470 415 462 468 425 469 440 334 342 322 322
Capital Work in Progress 5 119 119 109 98 76 56 47 36 24 17 1
Investments 2,136 35 54 41 39 52 41 0 0 50 36 25
Other Assets 0 4,622 4,010 4,066 3,749 3,686 3,271 3,062 2,164 2,410 2,062 2,425
LIABILITIES
Total Liabilities
Current Liabilities 166 172 150 189 169 118 124 122 95 86 75 62
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 2,966 2,850 2,849 2,712 2,524 2,550 2,573 2,239 1,778 2,057 1,839 2,033
Share Capital 45 45 45 45 45 45 45 34 34 35 35 37
Reserves & Surplus 2,921 2,806 2,805 2,667 2,479 2,505 2,528 2,195 1,744 2,021 1,804 1,996

BAYERCROP Cash Flow Statement — Operating, Investing & Financing

Bayer Crop Science operating cash flow ₹262 Cr, investing ₹86 Cr, financing ₹-619 Cr, net cash flow ₹-272 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 262 952 609 216 687 666 433 121 157 207 200
Investing Activities 86 0 83 64 7 -29 -113 38 -8 16 485
Financing Activities -619 -656 -613 -703 -556 -148 -158 -581 -73 -590 -42
Net Cash Flow -272 296 79 -424 138 489 162 -421 76 -367 644